Book – Responsible Opioid Prescribing: A Physician's Guide
Jointly Sponsored by the University of Wisconsin School of Medicine and Public Health, The Alliance of State Pain Initiatives, and the Federation of State Medical Boards.
 |
|
Activity Description
Target Audience and Scope of Practice
Physicians who prescribe opioid analgesics as part of pain management strategies in their clinical practice.
Elements of Competence
This CME activity has been designed to change patient care, medical knowledge, practice-based learning, interpersonal and communication skills, and professionalism, five of the six competencies embraced by the American Board of Medical Specialties.
Statement of Need
Opioid analgesics are the drugs of choice for the management of moderate to severe pain due to surgery, trauma, and cancer and may be essential in the treatment of persons with chronic non-cancer pain. Yet in spite of their documented effectiveness, they are often underutilized or used inappropriately. There is confusion about the risks associated with the use of these drugs, particularly about addiction. There is also evidence that physicians’ decisions about opioid prescribing have been influenced by their lack of knowledge about the laws and regulations that govern the prescribing of these drugs and their resultant fears of regulatory scrutiny.
This CME activity is designed to improve the knowledge of practicing physicians about the laws and regulations that govern the prescribing of opioid analgesics for pain control. It is specifically aimed at helping physicians learn the steps they can take to protect their practices from both unwarranted regulatory scrutiny and persons seeking opioids for non-medical purposes.
Objectives
Upon completion of this activity, participants should be able to:
- Describe the federal regulations that govern the prescribing and dispensing of opioid analgesics for pain control.
- Understand the simple steps they must take to be in compliance with controlled substances laws and regulations.
- Describe the basic components of an effective pain treatment plan.
- Distinguish among patients who have developed tolerance, physical dependence and/or addiction to opioid analgesics.
- Discuss approaches to use if a patient who is being treated with opioid analgesics exhibits behaviors that may be indicative of substance abuse.
Method of Participation
The estimated time to complete the activity and exam is 7 hours 15 min. To receive credit, a passing grade of 70% is required on a short online quiz. You will have one opportunity to retake the quiz to achieve a passing score. After you have completed your exam and evaluation you will be able to automatically print your credit letter.
Instructions & Computer Requirements
Instructions
To receive continuing education credits:
1) Purchase & read "Responsible Opioid Prescribing: A Physician's Guide"
2) If you have not already done so, register & pay $30 for this activity. You will receive an access code via email after completing the registration process. Be sure to save this code as you will need it to complete Step 3.
3) Complete and submit the online post-test and evaluation form. This requires three steps:
- If you do not already have one, create a user account for the UW Online CME portal.
- Sign up to receive credit for Responsible Opioid Prescribing (using the access code you received after registering and paying for the activity).
- Complete the Quiz & Evaluation.
4) Print your CME certificate. Select "View Certificate" from the "Quiz & Evaluation" results page, and then print the certificate for your records.
----------------------------------------------------
Computer Requirements
Free, current version of Internet Explorer, Netscape, Firefox, or Safari. (Some older browsers could produce error messages or not display the content correctly.)
Free, current version of Adobe Flash Player
Free, current version of Adobe Reader
Faculty & Educational Reviewer
Faculty
AUTHOR:
Scott M. Fishman, MD
Professor of Anesthesiology
Chief, Division of Pain Medicine
Department of Anesthesiology and Pain Medicine
University of California, Davis
Chairman, American Pain Foundation
Past President, American Academy of Pain Medicine
MEDICAL WRITER:
Stephen Braun
ASSOCIATE EDITORS:
Perry G. Fine, MD
Professor of Anesthesiology
School of Medicine, Pain Research Center
University of Utah, Salt Lake City, UT
Vice President for Medical Affairs
National Hospice and Palliative Care Organization
Alexandria, VA
Rollin M. Gallagher, MD, MPH
Clinical Professor of Psychiatry and Anesthesiology
Director, Center for Pain Medicine, Research and Policy
University of Pennsylvania School of Medicine
Director of Pain Management
Philadelphia VA Medical Center
Philadelphia, PA
Editor and Chief: PAIN MEDICINE, Journal of the Am. Academy of Pain Medicine
Aaron Gilson, PhD
Co-Director
US Policy Research Pain & Policy Studies Group/
World Health Organization Collaborating Center
University of Wisconsin-Madison
Madison, WI
Michael Moskowitz, MD, MPH
Assistant Professor of Anesthesiology and Pain Management
School of Medicine
University of California, Davis
Director, Bay Area Pain Medical Associates
Mill Valley, CA
ADVISORY BOARD:
Regina M. Benjamin, MD, MBA
Bayou Clinic
Bayou La Batre, AL
Chair, FSMB Board of Directors
Anton C. Bizzell, MD
Immediate Past Medical Officer
Center for Substance Abuse Treatment
Division of Pharmacologic Therapies
Substance Abuse & Mental Health Administration
Myra Christopher
President/CEO
Center for Practical Bioethics
Perry G. Fine, MD
Professor of Anesthesiology
University of Utah, School of Medicine
Rollin M. Gallagher, MD, MPH
Director, Center for Pain Medicine, Research & Policy
University of Pennsylvania
Aaron M. Gilson, PhD
Co-Director for US Policy Research
Pain & Policy Studies Group/WHO Collaborating Center
University of Wisconsin-Madison
William L. Harp, MD
Executive Director
Virginia Board of Medicine
Rebecca A. Kirch
Associate Director of Policy
American Cancer Society
Michael Moskowitz, MD
Assistant Professor, Anesthesiology and Pain Medicine,
School of Medicine, University of California, Davis
James N. Thompson, MD
Past President/CEO
Federation of State Medical Boards
David Thornton
Immediate Past Executive Director
Medical Board of California
PLANNING COMMITTEE:
Kelly C. Alfred, MS
Federation of State Medical Boards
Edward C. Covington, MD
Director, Neurological Center for Pain
Cleveland Clinic
June L. Dahl, PhD
Professor of Pharmacology
University of Wisconsin School of Medicine and Public Health
Perry G. Fine, MD
Bill H. McCarberg, MD
Founder, Chronic Pain Management
Kaiser Permanente
Ronna A. Popkin, MS
Outreach Coordinator
Alliance of State Pain Initiatives
Lisa A. Robin, MLA
Federation of State Medical Boards
David E. Weissman, MD
Medical College of Wisconsin
Educational Reviewer
Aaron Gilson, PhD
Credit
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health , the Alliance of State Pain Initiatives, and the Federation of State Medical Boards. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The University of Wisconsin School of Medicine and Public Health designates this educational activity for a maximum of 7.25 AMA PRA Category 1Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing Education Units: The University of Wisconsin-Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.725 Continuing Education Units (CEUs) or 7.25 hour(s).
NOTICE: The University of Wisconsin School of Medicine and Public Health advises the participant that one or more presentations in this continuing medical education activity does not contain reference(s) to unlabeled or unapproved uses of drugs or devices.
-------------------------------------------
University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin School of Medicine and Public Health fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify the Office of Continuing Professional Development in Medicine and Public Health.
Commercial Support
Jointly Sponsored by the University of Wisconsin School of Medicine and Public Health, The Alliance of State Pain Initiatives, and the Federation of State Medical Boards.
Supporters
This book has been supported by a consortium of organizations with a common interest in promoting safe and effective pain management, including:
Abbott Laboratories
Alliance of State Pain Initiatives
Alpharma Pharmaceuticals LLC
American Academy of Pain Medicine
American Cancer Society
American Pain Foundation
American Society for Pain Management Nursing
Candlelighters Childhood Cancer Foundation
Center for Practical Bioethics
Cephalon, Inc.
Endo Pharmaceuticals*
Federation of State Medical Boards Research and Education Foundation
International Association for Pain and Chemical Dependency
King Pharmaceuticals
Lance Armstrong Foundation
Mayday Fund
National Pain Foundation
Pain and Policy Studies Group, University of Wisconsin
Purdue Pharma L.P.
SAMHSA/CSAT (Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment)
*This commercial supporter provided an educational grant in support of this CME activity.
Faculty Disclosure
It is the policy of the University of Wisconsin School of Medicine and Public Health that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests* in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interest have been resolved and detailed disclosures are listed below:
The faculty reported the following:
Kelly C. Alfred, MS: No relevant financial relationships to disclose
Regina M. Benjamin, MD, MBA: Burger King, Con Agra Foods (Member of Advisory Committee)
Anton C. Bizzell, MD: No relevant financial relationships to disclose
Stephen Braun: No relevant financial relationships to disclose
Myra Christopher: No relevant financial relationships to disclose
Edward C. Covington, MD: No relevant financial relationships to disclose
June L. Dahl, PhD: Merck & Co. (Consultant); Abbott Laboratories, Endo Pharmaceuticals, Purdue Pharma L.P. (Principal Investigator)
Perry G. Fine, MD: Alpharma, Forest Laboratories, Ortho McNeil/Pricara, Purdue (Member of Advisory Board); Cephalon (Consultant); Janssen (Medical Expert)
Robert Fishman, DO: Cephalon, Inc.,Eli Lilly and Company (Consultant); Elan Co., Endo Pharmaceuticals, Janssen Medical Affairs, LLC, Merck & Co., Inc., Pfizer, Inc., & Purdue Pharma L.P. (Consultant, Speakers’ Bureau, Grants/Research Support)
Rollin M. Gallagher, MD, MPH: No relevant financial relationships to disclose
Aaron M. Gilson, PhD: Abbott Laboratories (Reviewer); Cephalon (Advisor); Purdue Pharma (Grantee)
William L. Harp, MD: No relevant financial relationships to disclose
Rebecca A. Kirch: No relevant financial relationships to disclose
Bill McCarberg, MD: Abbott Laboratories, Alpharma Pharmaceuticals, LLC, Cephalon,Eli Lilly , Endo Pharmaceuticals, Forest Laboratories, King Pharmaceuticals, Merck & Co., Inc, Ortho McNeil/Pricara, Pfizer, Inc., Purdue Pharma L.P., (Speaker)
Michael Moskowitz, MD, MPH: No relevant financial relationships to disclose
Ronna A. Popkin, MS: No relevant financial relationships to disclose
Lisa A. Robin, MLA: No relevant financial relationships to disclose
James N. Thompson, MD: No relevant financial relationships to disclose
David Thornton: No relevant financial relationships to disclose
David E. Weissman, MD: No relevant financial relationships to disclose
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Privacy Policy
The Office of Continuing Professional Development in Medicine and Public Health (OCPD) respects each site visitor's right to privacy. To prevent unauthorized access or disclosure, and to ensure the appropriate use of the information provided, we have in place physical and managerial procedures to safeguard the information we collect. Your information will never be given to anyone outside of the University of Wisconsin except to fulfill accreditation requirements. OCPD collects only the information necessary to provide you with the services that you ask for.
Register & Pay